Twitter | Search | |
Search Refresh
Janet Macpherson 24h
"From Stem Cells to Genes to Therapies" 13 - 15 November 2019, Brisbane ASSCR-AGCTS-ISCT ANZ 2019 JOINT SCIENTIFIC MEETING Abstract submissions close 2nd September. Come and join us
Reply Retweet Like
defeatHIV Aug 22
Our CAB member Laurie Sylla shared the data from our focus groups on the acceptability of cell & approaches to curing . Her talk's title perfectly captures the reactions from our participant: You Want Me to WHAT?
Reply Retweet Like
Premier Research 7h
While there were more than 2,400 trials conducted in 2017 alone, the science is still a long way from mainstream. So, if you’re planning a trial, here’s our advice: listen to experts.
Reply Retweet Like
Krystal Biotech Aug 20
KB103 study coordinator Dr. Peter Marinkovich was featured in speaking about trial results, future plans and the hope this developmental could give to all those affected by dystrophic . Read it here:
Reply Retweet Like
Friends4AnimalJustice Aug 9
❌CTA❌ PLS : Joe Kornegay: Jkornegay@cvm.tamu.edu President Michael K. Young PresidentYoung@tamu.edu To Stop Raising Dogs To Develop Muscular Diseases For Testing. + Of = :
Reply Retweet Like
Fumi Urano MD PhD Aug 21
Treatments for Wolfram Syndrome. Vision and Strategies.
Reply Retweet Like
ASGCT Aug 21
What is and how can it be used to treat disease? How does gene splicing help produce vaccines? provides a quick rundown of the elements of .
Reply Retweet Like
Behavioral Finance 23h
Reply Retweet Like
BioInformant Jul 6
FDA Grants RMAT To 's for Hemophilia A, SB-525
Reply Retweet Like
Caryn Heldt 9h
Awesome way to deliver vectors
Reply Retweet Like
Prasanna Shirol Aug 21
“The largest portfolio of products for in development of any company in the world.” What a great by a Father to the DIsease Community. A real inspiration. Congratulation Mr John Crowley
Reply Retweet Like
Li Weibo Institute for Rare Diseases Research Jul 17
Inspired by the opportunity to improve the lives of patients with debilitating disorders, Dr. Wolfe's lifelong goal as a scientist is to translate genome editing technologies to the development of therapeutics for a variety of diseases.
Reply Retweet Like
Lianna Orlando Jun 28
Great article on the results presented today
Reply Retweet Like
Albert Riehle Aug 22
A drug-inducible gene therapy approach in a new clinical trial said to be "more promising."
Reply Retweet Like
BioViva USA Inc Aug 21
The real value of these studies is uncovering pathways for - "This switch occurs through the activation of transcription factors called PPARs, which turn on many genes that are involved in metabolizing fatty acids.”
Reply Retweet Like
Mueller Lab Jul 22
It seems like only yesterday when we started this program in the lab! for
Reply Retweet Like
Cobra Biologics Aug 23
Interesting from illustrating the trends, challenges and developments associated with -->
Reply Retweet Like
defeatHIV Aug 22
Our event "MEDICAL ANGELS" can be accessed right now via the video of our livestreaming the conversation on Facebook: Listen to our 2 activists and our pioneer talk about attempts to cure or control their HIV
Reply Retweet Like
HutchIDSciences Aug 22
Laurie Sylla, MHSA, BSW You want me to what? Results of a qualitative study exploring acceptability of cell and gene therapy for hiv cure among a purposive sample of individuals receiving care at an HIV clinic in Seattle, WA
Reply Retweet Like
GEN Aug 22
. plans $500M expansion of R&D in Sanford, NC:
Reply Retweet Like